Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
All News
Headline News
Benzinga
Chartmill
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
StockStory
Stocktwits
Talk Markets
Press Releases
24-7 Press Release
AB Newswire
ACCESSWIRE
ACN Newswire
Authority Press Wire
Binary News Network
Brandpoint
Business Wire
CannabisNewsWire
CryptoCurrencyWire
Equities.com
eTrendy Stock
EZ Newswire
FinancialNewsMedia
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
News Direct
Newsfile
NewsUSA
Newswire.com
Newsworthy.ai
Press Advantage
Press Release Distribution Service
PressReach
PRLeap
PRLog
Prodigy
ReleaseWire
Small Business Trendsetters
Send2Press
StatePoint
Syndication Cloud
TheNewswire
Zexprwire
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
99
100
Next >
Bristol Myers Squibb to Report Results for Fourth Quarter 2024 on February 6, 2025
December 19, 2024
From
Bristol Myers Squibb
Via
Business Wire
Tickers
BMY
Lithium Royalty Corp. Announces US$28 Million Partial Sale of Tres Quebradas Royalty to Triple Flag Precious Metals
December 19, 2024
From
Lithium Royalty Corp.
Via
Business Wire
Tickers
TSX:LIRC
AECOM to support transformed mobility across Austin, Texas by delivering the city’s first light rail system
December 19, 2024
From
AECOM
Via
Business Wire
Tickers
ACM
Ventas Reaches Mutually Beneficial Agreements with Brookdale Senior Living
December 19, 2024
From
Ventas, Inc.
Via
Business Wire
Tickers
VTR
NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
December 19, 2024
From
NovaBay Pharmaceuticals
Via
Business Wire
Tickers
NBY
FIGS Announces Updates to Board of Directors
December 19, 2024
From
FIGS, Inc.
Via
Business Wire
Tickers
FIGS
CarMax Reports Third Quarter Fiscal Year 2025 Results
December 19, 2024
From
CarMax, Inc.
Via
Business Wire
Tickers
KMX
Merck Announces Topline Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) for the Treatment of Adults with Virologically Suppressed HIV-1 Infection
December 19, 2024
From
Merck & Co., Inc.
Via
Business Wire
Tickers
MRK
Accenture Reports First-Quarter Fiscal 2025 Results
December 19, 2024
From
Accenture
Via
Business Wire
Tickers
ACN
Matador Resources Company Successfully Closes Contribution of Pronto Midstream, LLC to San Mateo Midstream, LLC
December 19, 2024
From
Matador Resources Company
Via
Business Wire
Tickers
MTDR
Mitek to Participate in the 27th Annual Needham Growth Conference on January 14, 2025
December 19, 2024
From
Mitek Systems, Inc.
Via
Business Wire
Tickers
MITK
P3 Partners Oral Surgery Launches Ambitious Practice Acquisition Campaign, Seeking Passionate Oral and Maxillofacial Surgeons to Join Our Growing Team
December 19, 2024
From
P3 Partners Oral Surgery
Via
Business Wire
APLT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
December 19, 2024
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Tickers
APLT
Lamb Weston Announces Appointment of Michael J. Smith as President and Chief Executive Officer
December 19, 2024
From
Lamb Weston Holdings, Inc.
Via
Business Wire
Tickers
LW
Roam For the Holidays: Grindr Offers Free Access to Their Popular Travel Feature
December 19, 2024
From
Grindr Inc.
Via
Business Wire
Tickers
GRND
ACRO Announces 2025 Officers and New Members
December 19, 2024
From
ACRO
Via
Business Wire
Portal Biotechnologies Announces Over 50 Partnerships and Oversubscribed $7M Seed Round Led by IA Ventures
December 19, 2024
From
Portal Biotechnologies, Inc.
Via
Business Wire
Genesis Energy, L.P. Announces Early Results and Initial Settlement Date for Tender Offer for Up to $575 Million Aggregate Principal Amount of Its 8.0% Senior Notes Due 2027
December 19, 2024
From
Genesis Energy, L.P.
Via
Business Wire
Tickers
GEL
Regis Corporation Acquires Alline Salon Group Adding $83M Revenue and $5.8M EBITDA
December 19, 2024
From
Regis Corporation
Via
Business Wire
Tickers
RGS
Red Arts Capital Acquires KKSP Precision Machining, LLC and Add-On Hy-Production, Inc.
December 19, 2024
From
Red Arts Capital
Via
Business Wire
Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy
December 19, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Tickers
VRTX
Lamb Weston Reports Second Quarter Fiscal 2025 Results; Board Approves $250 Million Share Repurchase Authorization Increase and Increases Quarterly Dividend; Updates Fiscal Year 2025 Outlook
December 19, 2024
From
Lamb Weston Holdings, Inc.
Via
Business Wire
Tickers
LW
COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics
December 19, 2024
From
COTA Inc.
Via
Business Wire
Tickers
GH
Rainier Partners Announces Platform Investment in Welfare & Pension Administration Service
December 19, 2024
From
Rainier Partners
Via
Business Wire
U.S. C-Suite Optimistic for 2025, but U.S. Presidential Election, Global Events and Regulatory Environment Loom Large
December 19, 2024
From
Altum Strategy Group
Via
Business Wire
Ampion Brings Clean Energy, Savings to Mainers with 5 New Community Solar Sites
December 19, 2024
From
Ampion Renewable Energy
Via
Business Wire
Palleon Pharmaceuticals and Henlius Collaborate to Advance Glycan Editing as a Treatment for Autoimmune Diseases
December 19, 2024
From
Palleon Pharmaceuticals
Via
Business Wire
AI Explainability Uncovers Surprising Truth About Jesse James in New Documentary
December 19, 2024
From
Corsight AI
Via
Business Wire
Strike Narrowly Averted as Unions Reach Settlement with Save Mart/Lucky/FoodMaxx
December 19, 2024
From
UFCW 8-Golden State
Via
Business Wire
A Phase 3 Ready DMD Gene Therapy, a Clinical Trial to Offset AAV Neutralizing Antibodies, and an AI Inspired New Generation of Capsids Highlight Genethon’s 2024 Fall Milestones
December 19, 2024
From
Genethon
Via
Business Wire
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.